Isovaleric acid
|
Basic information |
| Metabolite name | Isovaleric acid |
 | HMDB0000718 |
 |
C08262 |
 |
10430 |
| Synonyms | 3-Methylbutanoic acid; |
| No. of studies | 13 |
|
Basic information |
| Metabolite name | Isovaleric acid |
| HMDB0000718 |
|
C08262 |
|
10430 |
| Synonyms | 3-Methylbutanoic acid; |
| No. of studies | 13 |
|
Relationship between Isovaleric acid and depression (count: 13) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1009 | Type2 | CUMS + multi-probiotics group vs. CUMS group | Faece | C57BL/6 mouse | Up |
| Study M1019 | Type1 | depression group vs. control group | Serum | Human | Down |
| Study M1025 | Type2 | CUMS + Bacillus licheniformis group vs. CUMS group | Faece | Sprague-Dawley rat | Up |
| Study M1026 | Type2 | CUMS + Bacillus licheniformis group vs. CUMS group | Faece | Sprague-Dawley rat | Up |
| Study M1027 | Type1 | CUMS group vs. control group | Faece | Wistar rat | Down |
| Study M1027 | Type2 | CUMS + fluoxetine group vs. CUMS group | Faece | Wistar rat | Up |
| Study M1027 | Type2 | CUMS + high dose of berberine group vs. CUMS group | Faece | Wistar rat | Up |
| Study M1027 | Type2 | CUMS + low dose of berberine group vs. CUMS group | Faece | Wistar rat | Up |
| Study M667 | Type1 | CRS group vs. control group | Faece | C57BL/6 J mouse | Down |
| Study M667 | Type2 | CRS + crocin-I group vs. CRS group | Faece | C57BL/6 J mouse | Up |
| Study M706 | Type1 | CUMS group vs. control group | Faece | C57BL/6 mouse | Down |
| Study M706 | Type2 | CUMS + CCFM1025 group vs. CUMS group | Faece | C57BL/6 mouse | Up |
| Study M804 | Type1 | CUMS group vs. control group | Faece | Sprague-Dawley rat | Down |
| Study M804 | Type2 | CUMS + high dose of WYJYD group vs. CUMS group | Faece | Sprague-Dawley rat | Up |
| Study M804 | Type2 | CUMS + middle dose of WYJYD group vs. CUMS group | Faece | Sprague-Dawley rat | Up |
| Study M804 | Type2 | CUMS + fluoxetine group vs. CUMS group | Faece | Sprague-Dawley rat | Up |
| Study M872 | Type3 | rifaximin group vs. control group | Brain | Sprague-Dawley rat | Up |
| Study M886 | Type2 | lead-exposed + probiotics group vs. lead-exposed group | Faece | Sprague-Dawley rat | Up |
| Study M900 | Type1 | CUMS group vs. control group | Faece | Sprague-Dawley rat | Up |
| Study M900 | Type2 | CUMS + Semen Sojae Praeparatum group vs. CUMS group | Faece | Sprague-Dawley rat | Down |
| Study M901 | Type1 | LPS group vs. control group | Faece | C57BL/6 mouse | Up |
| Study M901 | Type2 | LPS + Schisandrin group vs. LPS group | Faece | C57BL/6 mouse | Down |
| Study M985 | Type2 | CUMS + indole acetic acid group vs. CUMS group | Cecum | C57BL/6J mouse | Up |